This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow [Online Table]
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humphries, K. H.
Right arrow Articles by Gill, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humphries, K. H.
Right arrow Articles by Gill, S.
Related Collections
Right arrow Drugs
Right arrow Menopause (including HRT)
Right arrowRelated Article
CMAJ • April 15, 2003; 168 (8)
© 2003 Canadian Medical Association or its licensors


Review
Synthèse

Risks and benefits of hormone replacement therapy: The evidence speaks

Karin H. Humphries and Sabrina Gill

From the Division of Cardiology (Humphries) and the Division of Endocrinology and Metabolism (Gill), Department of Medicine, St. Paul's Hospital, University of British Columbia and Centre for Health Evaluation & Outcome Sciences, Vancouver, BC.

Correspondence to: Dr. Sabrina Gill, Division of Endocrinology and Metabolism, St. Paul's Hospital, Rm. 467, Comox Building, 1081 Burrard St., Vancouver BC V6Z 1Y6; fax 604 806-8594; sgill{at}providencehealth.bc.ca

Abstract

UNTIL RECENTLY, OBSERVATIONAL STUDIES suggested a decreased risk of cardiovascular disease, osteoporotic fractures, cognitive decline and colon cancer with the use of hormone replacement therapy (HRT). Recent randomized controlled trials have failed to show a protective effect of HRT in reducing the risk of coronary artery disease and instead have revealed an increased risk of heart disease, stroke, invasive breast cancer and venous thromboembolism, but a decreased risk of colorectal cancer and osteoporotic fractures. In this article we review the current evidence of the risks and benefits of HRT.



Related Article

Highlights of this issue
Can. Med. Assoc. J. 2003 168: 953. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
K.-M. Suzuki, Y. Isohama, H. Maruyama, Y. Yamada, Y. Narita, S. Ohta, Y. Araki, T. Miyata, and S. Mishima
Estrogenic Activities of Fatty Acids and a Sterol Isolated from Royal Jelly
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
E. Wooltorton
Combination hormone replacement therapy and dementia
Can. Med. Assoc. J., July 22, 2003; 169(2): 133 - 133.
[Full Text] [PDF]

eLetters:

Read all eLetters

delayed institution of hrt
John H Pearson
CMAJ, 17 Nov 2003 [Full text]